Where Success Begins

Science-led integrated drug discovery: medicinal and synthetic chemistry, computational chemistry, in vitro biosciences, DMPK, compound management and diversity and fragment libraries.

Read more

About Us

BioAscent is a leading provider of integrated drug discovery services

Founded in 2013, BioAscent is a leading provider of integrated drug discovery services based at the former Organon / MSD R&D site in Newhouse, Scotland, UK. Our drug discovery services include de novo assay development, target analysis and bespoke screening strategies, compound screening (including HTS), medicinal and synthetic chemistry, computational chemistry and compound management, all with access to in-house diversity and fragment libraries.

Read more

News

US biotech uses BioAscent’s compound management service to accelerate screening of 250k library across multiple campaigns

08 July 2024


A US biotech company has partnered with compound management experts BioAscent to build, consolidate and manage its scree...

Read more

BioAscent team key part of collaborative European Lead Factory study to identify small molecule inhibitors of a DNA repair nuclease (SNM1A)

26 June 2024


The recently published paper, Cell-active small molecule inhibitors validate the SNM1A DNA repair nuclease as a cancer t...

Read more

Highlights in synthesis - unnatural amino acids

24 June 2024


Unnatural amino acids are key building blocks in medicinal chemistry.  These motifs are frequently integrated into drug-...

Read more

BioAscent obtains cyber essentials plus accreditation

12 June 2024


BioAscent has received Cyber Essentials Plus certification, demonstrating the company’s commitment to cyber security.Cyb...

Read more

Integrated Drug Discovery


Science-led drug discovery

Get in Touch

Let's talk about how we can maximise your drug discovery success.

Contact